Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.09.15.676424

Transcriptomic Mutational Profiling of Gastric Adenocarcinoma in Northern Brazil

Abstract

Gastric cancer (GC) remains among the neoplasms with the worst prognosis, partly due to its biological heterogeneity and the scarcity of robust biomarkers. The characterization of mutational profiles from transcripts can reveal specific tumor signatures and point to therapeutic targets. This study investigated the landscape of mutations expressed in 102 samples of gastric adenocarcinoma from northern Brazil, which were sequenced using NGS. Readings were aligned to the reference genome using STAR (two-pass mode), and variants were called with GATK and VarDict. Annotations and impact predictions were generated using VEP, SIFT, and PolyPhen. We identified >90,000 variants; among the most frequently mutated genes, FTH1 stood out. The mutational profile was described using maftools, and signatures were inferred with MutationalPatterns. We observed a predominant distribution of SNVs, with C>T transitions as the most common event, in addition to patterns compatible with signatures related to replication damage and DNA repair. To mitigate biases inherent to RNA-seq, we applied filters for coverage, strand bias, and RNA editing hotspots. Together, the data outline a regional landscape of mutations expressed in GC and reinforce the usefulness of the transcriptome for prioritizing biomarkers and functional hypotheses that may guide genomic validations and subsequent clinical studies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

da Silva, R. F., Pereira, D. F., Mourao, R. M. d. S., Avelar, D. d. S., da Silva, J. M. C., Santos da Silva, V. C., Tavares, M. S., Pinto, J. B. A., Casseb, S. M. M., Demachki, S., Barra, W. F., Vidal, A. F., Ishak, G., Assumpcao, P. P., Burbano, R. M. R., Moreira, F.. 2025-09-18. Transcriptomic Mutational Profiling of Gastric Adenocarcinoma in Northern Brazil. https://doi.org/10.1101/2025.09.15.676424

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Machine Learning-Enhanced Mucosal Luminal Interface Metaproteomics Reveals Diagnostic Potential of Microbial Proteins in Pediatric Inflammatory Bowel Disease

Abstract: Background: Inflammatory Bowel Disease (IBD), a chronic gastrointestinal disorder with two main subtypes, Crohn's Disease (CD) and Ulcerative Colitis (UC), is associated with more aggressive phenotypes and greater diagnostic complexity in pediatric patients. Conventional diagnostic biomarkers, lack sufficient distinguishing power between IBD subtypes. This study aimed to investigate and compare proteomic and metaproteomic profiles of pediatric IBD (PIBD) patients and healthy controls to develop a diagnostic panel capable of accurately diagnose IBD and distinguish its subtypes. Methods: We performed an in-depth evaluation of mucosal luminal interface samples from PIBD patients and healthy individuals, separately analyzing both the human proteome and microbial metaproteome data. The study involved selecting appropriate protein sets, employing feature selection techniques and machine learning across three intestinal regions: the terminal ileum, ascending colon, and descending colon. Results: Notably, panels composed solely of microbial biomarkers outperformed both human-only and combined human-microbial panels, achieving highly accurate results. Furthermore, the ascending colon emerged as the optimal sampling site, a result that aligns with the rich microbial diversity revealed in its taxonomic profile. Conclusions: Using a machine learning-based strategy on combined proteomics and metaproteomics, this study uncovered disease-relevant signaling pathways and delivered taxonomic as well as functional insights into the microbial dysbiosis of PIBD. A diagnostic panel built around microbial proteins (particularly those originating from the ascending colon) emerges as a promising tool for more precise stratification of PIBD subtypes. Larger, prospective studies are now needed to validate these candidate biomarkers and translate them into clinically deployable diagnostic panels. Keywords: Metaproteome, Biomarker, Pediatric Inflammatory bowel disease, Machine learning, Mucosal luminal interface.

bioinformatics↗

Revealing the transcriptomic organization of extrasomatic interfaces using SCOUBI

Spatial transcriptomics (ST) generates substantial transcript signal outside segmented cell bodies, which is generally discarded by analysis tools. This is especially problematic for brain ST data, as neuronal mRNAs can be localized far from somata - in axons, dendrites, and synaptic compartments - and up to half of the transcripts in ST data may lie outside cell bodies. Here, we present SCOUBI, a computational framework that identifies axon-dendrite interfaces from extrasomatic RNA in ST data, revealing a hitherto overlooked layer of molecular function in neural tissues. It first partitions extrasomatic space into axon- and dendrite-enriched compartments based on known marker genes, using a neural network trained to maximize marker specificity and inter-compartment communication signals. It then defines interfaces as loci where predicted axonal and dendritic compartments converge and exhibit ligand-receptor colocalization. Applied to mouse brain, SCOUBI creates maps of axonal and dendritic compartments and their interfaces that align with known spatial patterns of neurite and synaptic distribution. It identifies transcriptomic differences between interfaces and the surrounding extrasomatic space, revealing region-specific signatures of neuronal signaling and synaptic plasticity. By comparing interface transcript enrichment with local somatic expression, SCOUBI identifies genes that preferentially localize at sites of intercellular communication rather than simply reflecting nearby cell bodies. SCOUBI reveals interface-associated transcripts beyond established synaptic genes, with molecular signatures reproducible across independent samples and imaging platforms. In summary, SCOUBI transforms a substantial and often-discarded aspect of ST data into an interpretable readout of subcellular organization and neural signaling.

bioinformatics↗

Joint Analysis of Common Regulatory and Rare Coding Variants for Improved Power in Kernel Association Tests

Rare alleles arise from mutations on an existing haplotype background, yet current gene-based rare variant association tests treat low-frequency coding variants as effects independent of the common regulatory variants that surround them. The penetrance of rare coding variants can be modulated by the cis-regulatory landscape, and failing to account for this context limits the statistical power of existing methods for complex traits. We present PrediXSKAT, a kernel-based rare variant association framework that incorporates the surrounding cis-regulatory landscape by estimating its impact on gene expression via PrediXcan. PrediXSKAT embeds predicted gene expression directly into the Sequence Kernel Association Test kernel through element-wise similarity weighting, concentrating rare variant signal among individuals who share concordant genetic and regulatory backgrounds. Comprehensive simulations demonstrate that PrediXSKAT increases power over standard kernel-based testing under biologically realistic conditions where a proportion of tested variants carry small, mixed-direction effects. Type I error rates are controlled in the absence of association. Power gains persist across a range of sample sizes and causal variant architectures. Applied to whole-genome sequencing data from the Alzheimer's Disease Sequencing Project, PrediXSKAT recapitulates established disease loci and amplifies signals at previously unreported candidate genes without indiscriminately inflating genome-wide results. PrediXSKAT provides a generalizable and extensible framework for the joint analysis of common regulatory and rare coding variants. The approach can be applied to any kernel-based set test and extended to jointly consider multiple genes within the same biological pathway, offering a principled strategy for improving rare variant discovery in large-scale sequencing studies of complex disease.

bioinformatics↗